Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Lactobacillus reuteri DSM 17938 and Achieved Complete Symptom Cessation

Doses used in studies

CFU/day: 100 million (median 100 million, IQR 100 million–100 million) — 1 study

1 of 1 paper

Lactobacillus reuteri DSM 17938 is effective in the treatment of functional abdominal pain in children: Results of the double-blind randomized study.
- 2020-12
- RCT · n = 147
- Clinical Nutrition 39(12)
- - O. Jadrešin
  - Sara Sila
  - I. Trivić
  - Z. Mišak
  - S. Kolaček
  - I. Hojsak
- PubMed: 32362486
- DOI: 10.1016/j.clnu.2020.04.019
7 Insights on
- Achieved Complete Symptom Cessation
- High evidence
There was no difference between groups in the number of children in whom symptoms completely ceased (Risk Ratio 1.09, 95% CI 0.75-1.58)
Effect
Neutral
Effect size
Small
Significant
No
Dose
10^8 CFU/day